Keyphrases
Tumor-targeted Therapy
100%
Lung Cancer
83%
Premalignancy
62%
Non-small Cell Lung Cancer (NSCLC)
41%
Clinical Investigator
41%
Therapeutic Strategies
41%
Anti-EGFR Antibody
25%
Junior Staff
25%
Intrapleural Therapy
25%
Pulmonary Surgery
25%
Clinical Trials
20%
Antitumor Effect
20%
Inhaled Therapeutics
20%
Therapy Research
20%
Chemotherapy
20%
Molecular Parameters
20%
Lung Cancer Treatment
20%
Aerosolized
20%
Therapeutic Modalities
20%
C225
20%
Staff Members
20%
Dysregulated
20%
Malignant Pleural Effusion
20%
Drug Delivery
20%
Liposomes
20%
Pulmonary Medicine
20%
Medical Oncology
20%
Mentorship
20%
TP53 mutation
20%
Synergism
20%
Translational Research
20%
Molecular Targets
20%
Pharmacological Parameter
20%
Clinical Evaluation
20%
Hematology
20%
Medicine and Dentistry
Neoplasm
100%
Targeted Therapy
100%
Lung Cancer
100%
Precancerous Condition
60%
Clinical Trial
40%
Non-Small Cell Lung Cancer
40%
Protein P53
40%
Division
20%
Hematology
20%
Intrapleural Drug Administration
20%
Malignant Pleural Effusion
20%
Epidermal Growth Factor Receptor
20%
Translational Research
20%
Liposome
20%
Clinical Study
20%
Therapeutic Modality
20%
Medical Oncology
20%
Cetuximab
20%
Respiratory Medicine
20%
Cancer Therapy
20%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Lung Cancer
100%
Precancer
60%
Protein P53
40%
Clinical Trial
40%
Cetuximab
20%
Liposome
20%
Synergism
20%
Epidermal Growth Factor Receptor
20%
Clinical Study
20%
Malignant Pleura Effusion
20%
Chemotherapy
20%